Average Co-Inventor Count = 6.22
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (25 from 3,681 patents)
2. E. R. Squibb Sons, Inc. (2 from 1,624 patents)
27 patents:
1. 10174024 - 5H-pyrido[3,2-B]indole compounds as anticancer agents
2. 9751879 - Tricyclic compounds as anticancer agents
3. 9725449 - Tricyclic compounds as anticancer agents
4. 9492460 - Carbazole compounds useful as bromodomain inhibitors
5. 9427442 - Fluoroalkyl and fluorocycloalkyl 1,4-benzodiazepinone compounds
6. 9273075 - Prodrugs of 1,4-benzodiazepinone compounds
7. 9242941 - Alkyl, fluoroalkyl-1,4-benzodiazepinone compounds
8. 9242940 - N-substituted bis(fluoroalkyl)-1,4-benzodiazepinone compounds
9. 9133139 - Fluoroalkyl-1,4-benzodiazepinone compounds
10. 8067582 - Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function
11. 7846931 - Pyrrolotriazine compounds as kinase inhibitors
12. 7468439 - Alkylene bridged sultam compounds useful as modulators of nuclear hormone receptor function
13. 7417040 - Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
14. 7378426 - Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
15. 7297695 - Pyrrolotriazine compounds as kinase inhibitors